AUTL
Autolus Therapeutics
AUTL
AUTL
108 hedge funds and large institutions have $395M invested in Autolus Therapeutics in 2024 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 33 increasing their positions, 30 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
3.87% less ownership
Funds ownership: 67.12% → 63.26% (-3.9%)
39% less capital invested
Capital invested by funds: $648M → $395M (-$253M)
77% less call options, than puts
Call options by funds: $84K | Put options by funds: $362K
Holders
108
Holding in Top 10
2
Calls
$84K
Puts
$362K
Top Buyers
| 1 | +$7.5M | |
| 2 | +$5.47M | |
| 3 | +$4.29M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$2.64M |
| 5 |
Millennium Management
New York
|
+$1.86M |
Top Sellers
| 1 | -$13.2M | |
| 2 | -$10.7M | |
| 3 | -$9.5M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$5.72M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.03M |